APO Research
Talk to an analyst

APO RESEARCH · REPORT

Malaria Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Malaria Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchMalaria Drugs Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Malaria Drugs Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Malaria Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Malaria Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Malaria Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Malaria Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Malaria Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Malaria Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Malaria Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Malaria Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Malaria Drugs include Ajanta Pharma, Cipla, Guilin Pharmaceutical, IPCA Laboratories, Sanofi Aventis, GlaxoSmithKline, Kunming Pharmaceutical, Roche and Mylan Labs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Malaria Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Malaria Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Malaria Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Malaria Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Malaria Drugs Segment by Company

Ajanta Pharma

Cipla

Guilin Pharmaceutical

IPCA Laboratories

Sanofi Aventis

GlaxoSmithKline

Kunming Pharmaceutical

Roche

Mylan Labs

Novartis

Malaria Drugs Segment by Type

Artemisinin Compounds

Antifolate Compounds

Aryl Aminoalcohol Compounds

Malaria Drugs Segment by Application

Prevention

Treatment

Other

Malaria Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Malaria Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Malaria Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Malaria Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Malaria Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Malaria Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Malaria Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Malaria Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Malaria Drugs Industry Trends Table 2. Malaria Drugs Industry Drivers Table 3. Malaria Drugs Industry Opportunities and Challenges Table 4. Malaria Drugs Industry Restraints Table 5. Global Malaria Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Malaria Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Malaria Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Malaria Drugs Sales Market Share by Manufacturers Table 9. Global Malaria Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Malaria Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Malaria Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Malaria Drugs Manufacturers, Product Type & Application Table 13. Global Malaria Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Malaria Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Artemisinin Compounds Table 17. Major Manufacturers of Antifolate Compounds Table 18. Major Manufacturers of Aryl Aminoalcohol Compounds Table 19. Global Malaria Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Malaria Drugs Sales by Type (2021-2026) & (k units) Table 21. Global Malaria Drugs Sales by Type (2027-2032) & (k units) Table 22. Global Malaria Drugs Sales Market Share by Type (2021-2026) Table 23. Global Malaria Drugs Sales Market Share by Type (2027-2032) Table 24. Global Malaria Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Malaria Drugs Revenue by Type (2021-2026) & (k units) Table 26. Global Malaria Drugs Revenue by Type (2027-2032) & (k units) Table 27. Global Malaria Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Malaria Drugs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Prevention Table 30. Major Manufacturers of Treatment Table 31. Major Manufacturers of Other Table 32. Global Malaria Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Malaria Drugs Sales by Application (2021-2026) & (k units) Table 34. Global Malaria Drugs Sales by Application (2027-2032) & (k units) Table 35. Global Malaria Drugs Sales Market Share by Application (2021-2026) Table 36. Global Malaria Drugs Sales Market Share by Application (2027-2032) Table 37. Global Malaria Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Malaria Drugs Revenue by Application (2021-2026) & (k units) Table 39. Global Malaria Drugs Revenue by Application (2027-2032) & (k units) Table 40. Global Malaria Drugs Revenue Market Share by Application (2021-2026) Table 41. Global Malaria Drugs Revenue Market Share by Application (2027-2032) Table 42. Global Malaria Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Malaria Drugs Sales by Region (2021-2026) & (k units) Table 44. Global Malaria Drugs Sales Market Share by Region (2021-2026) Table 45. Global Malaria Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Malaria Drugs Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Malaria Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Malaria Drugs Sales by Country (2021-2026) & (k units) Table 49. North America Malaria Drugs Sales by Country (2027-2032) & (k units) Table 50. Europe Malaria Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Malaria Drugs Sales by Country (2021-2026) & (k units) Table 52. Europe Malaria Drugs Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Malaria Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Malaria Drugs Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Malaria Drugs Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Malaria Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Malaria Drugs Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Malaria Drugs Sales by Country (2027-2032) & (k units) Table 59. Global Malaria Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Malaria Drugs Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Malaria Drugs Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Malaria Drugs Revenue Market Share by Region (2021-2026) Table 63. Global Malaria Drugs Revenue Market Share by Region (2027-2032) Table 64. Ajanta Pharma Company Information Table 65. Ajanta Pharma Business Overview Table 66. Ajanta Pharma Malaria Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Ajanta Pharma Malaria Drugs Product Portfolio Table 68. Ajanta Pharma Recent Development Table 69. Cipla Company Information Table 70. Cipla Business Overview Table 71. Cipla Malaria Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Cipla Malaria Drugs Product Portfolio Table 73. Cipla Recent Development Table 74. Guilin Pharmaceutical Company Information Table 75. Guilin Pharmaceutical Business Overview Table 76. Guilin Pharmaceutical Malaria Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Guilin Pharmaceutical Malaria Drugs Product Portfolio Table 78. Guilin Pharmaceutical Recent Development Table 79. IPCA Laboratories Company Information Table 80. IPCA Laboratories Business Overview Table 81. IPCA Laboratories Malaria Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. IPCA Laboratories Malaria Drugs Product Portfolio Table 83. IPCA Laboratories Recent Development Table 84. Sanofi Aventis Company Information Table 85. Sanofi Aventis Business Overview Table 86. Sanofi Aventis Malaria Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Sanofi Aventis Malaria Drugs Product Portfolio Table 88. Sanofi Aventis Recent Development Table 89. GlaxoSmithKline Company Information Table 90. GlaxoSmithKline Business Overview Table 91. GlaxoSmithKline Malaria Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. GlaxoSmithKline Malaria Drugs Product Portfolio Table 93. GlaxoSmithKline Recent Development Table 94. Kunming Pharmaceutical Company Information Table 95. Kunming Pharmaceutical Business Overview Table 96. Kunming Pharmaceutical Malaria Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Kunming Pharmaceutical Malaria Drugs Product Portfolio Table 98. Kunming Pharmaceutical Recent Development Table 99. Roche Company Information Table 100. Roche Business Overview Table 101. Roche Malaria Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Roche Malaria Drugs Product Portfolio Table 103. Roche Recent Development Table 104. Mylan Labs Company Information Table 105. Mylan Labs Business Overview Table 106. Mylan Labs Malaria Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Mylan Labs Malaria Drugs Product Portfolio Table 108. Mylan Labs Recent Development Table 109. Novartis Company Information Table 110. Novartis Business Overview Table 111. Novartis Malaria Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Novartis Malaria Drugs Product Portfolio Table 113. Novartis Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Malaria Drugs Distributors List Table 117. Malaria Drugs Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Malaria Drugs Product Image Figure 2. Global Malaria Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Malaria Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Malaria Drugs Sales (2021-2032) & (k units) Figure 5. Global Malaria Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Malaria Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Artemisinin Compounds Image Figure 9. Antifolate Compounds Image Figure 10. Aryl Aminoalcohol Compounds Image Figure 11. Global Malaria Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Malaria Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Malaria Drugs Sales Market Share by Type (2021-2032) Figure 14. Global Malaria Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Malaria Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Malaria Drugs Revenue Market Share by Type (2021-2032) Figure 17. Prevention Image Figure 18. Treatment Image Figure 19. Other Image Figure 20. Global Malaria Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Malaria Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Malaria Drugs Sales Market Share by Application (2021-2032) Figure 23. Global Malaria Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Malaria Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Malaria Drugs Revenue Market Share by Application (2021-2032) Figure 26. North America Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Malaria Drugs Sales Market Share by Country (2021-2032) Figure 28. U.S. Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Malaria Drugs Sales Market Share by Country (2021-2032) Figure 33. Germany Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Malaria Drugs Sales Market Share by Country (2021-2032) Figure 40. China Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Malaria Drugs Sales Market Share by Country (2021-2032) Figure 48. Brazil Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Malaria Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Malaria Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Malaria Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Malaria Drugs Revenue (2021-2032) & (US$ Million) Figure 59. North America Malaria Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Malaria Drugs Revenue (2021-2032) & (US$ Million) Figure 61. Europe Malaria Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Malaria Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Malaria Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Malaria Drugs Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Malaria Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Malaria Drugs Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Malaria Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Artemisinin Compounds
  • Antifolate Compounds
  • Aryl Aminoalcohol Compounds
Applications
  • Prevention
  • Treatment
  • Other
Companies covered
  • Ajanta Pharma
  • Cipla
  • Guilin Pharmaceutical
  • IPCA Laboratories
  • Sanofi Aventis
  • GlaxoSmithKline
  • Kunming Pharmaceutical
  • Roche
  • Mylan Labs
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Malaria Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Malaria Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Malaria Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Malaria Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Malaria Drugs Market Dynamics
  1. 2.1 Malaria Drugs Industry Trends
  2. 2.2 Malaria Drugs Industry Drivers
  3. 2.3 Malaria Drugs Industry Opportunities and Challenges
  4. 2.4 Malaria Drugs Industry Restraints
3 Malaria Drugs Market by Manufacturers
  1. 3.1 Global Malaria Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Malaria Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Malaria Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Malaria Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Malaria Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Malaria Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Malaria Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Malaria Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Malaria Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Malaria Drugs Tier 1, Tier 2, and Tier 3
4 Malaria Drugs Market by Type
  1. 4.1 Malaria Drugs Type Introduction
  2. 4.1.1 Artemisinin Compounds
  3. 4.1.2 Antifolate Compounds
  4. 4.1.3 Aryl Aminoalcohol Compounds
  5. 4.2 Global Malaria Drugs Sales by Type
  6. 4.2.1 Global Malaria Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Malaria Drugs Sales by Type (2021-2032)
  8. 4.2.3 Global Malaria Drugs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Malaria Drugs Revenue by Type
  10. 4.3.1 Global Malaria Drugs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Malaria Drugs Revenue by Type (2021-2032)
  12. 4.3.3 Global Malaria Drugs Revenue Market Share by Type (2021-2032)
5 Malaria Drugs Market by Application
  1. 5.1 Malaria Drugs Application Introduction
  2. 5.1.1 Prevention
  3. 5.1.2 Treatment
  4. 5.1.3 Other
  5. 5.2 Global Malaria Drugs Sales by Application
  6. 5.2.1 Global Malaria Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Malaria Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Malaria Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Malaria Drugs Revenue by Application
  10. 5.3.1 Global Malaria Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Malaria Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Malaria Drugs Revenue Market Share by Application (2021-2032)
6 Global Malaria Drugs Sales by Region
  1. 6.1 Global Malaria Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Malaria Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Malaria Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Malaria Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Malaria Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Malaria Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Malaria Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Malaria Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Malaria Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Malaria Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Malaria Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Malaria Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Malaria Drugs Revenue by Region
  1. 7.1 Global Malaria Drugs Revenue by Region
  2. 7.1.1 Global Malaria Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Malaria Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Malaria Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Malaria Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Malaria Drugs Revenue (2021-2032)
  8. 7.2.2 North America Malaria Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Malaria Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Malaria Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Malaria Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Malaria Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Malaria Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Malaria Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Ajanta Pharma
  2. 8.1.1 Ajanta Pharma Company Information
  3. 8.1.2 Ajanta Pharma Business Overview
  4. 8.1.3 Ajanta Pharma Malaria Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ajanta Pharma Malaria Drugs Product Portfolio
  6. 8.1.5 Ajanta Pharma Recent Developments
  7. 8.2 Cipla
  8. 8.2.1 Cipla Company Information
  9. 8.2.2 Cipla Business Overview
  10. 8.2.3 Cipla Malaria Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cipla Malaria Drugs Product Portfolio
  12. 8.2.5 Cipla Recent Developments
  13. 8.3 Guilin Pharmaceutical
  14. 8.3.1 Guilin Pharmaceutical Company Information
  15. 8.3.2 Guilin Pharmaceutical Business Overview
  16. 8.3.3 Guilin Pharmaceutical Malaria Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Guilin Pharmaceutical Malaria Drugs Product Portfolio
  18. 8.3.5 Guilin Pharmaceutical Recent Developments
  19. 8.4 IPCA Laboratories
  20. 8.4.1 IPCA Laboratories Company Information
  21. 8.4.2 IPCA Laboratories Business Overview
  22. 8.4.3 IPCA Laboratories Malaria Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 IPCA Laboratories Malaria Drugs Product Portfolio
  24. 8.4.5 IPCA Laboratories Recent Developments
  25. 8.5 Sanofi Aventis
  26. 8.5.1 Sanofi Aventis Company Information
  27. 8.5.2 Sanofi Aventis Business Overview
  28. 8.5.3 Sanofi Aventis Malaria Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Aventis Malaria Drugs Product Portfolio
  30. 8.5.5 Sanofi Aventis Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Malaria Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Malaria Drugs Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Kunming Pharmaceutical
  38. 8.7.1 Kunming Pharmaceutical Company Information
  39. 8.7.2 Kunming Pharmaceutical Business Overview
  40. 8.7.3 Kunming Pharmaceutical Malaria Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kunming Pharmaceutical Malaria Drugs Product Portfolio
  42. 8.7.5 Kunming Pharmaceutical Recent Developments
  43. 8.8 Roche
  44. 8.8.1 Roche Company Information
  45. 8.8.2 Roche Business Overview
  46. 8.8.3 Roche Malaria Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Roche Malaria Drugs Product Portfolio
  48. 8.8.5 Roche Recent Developments
  49. 8.9 Mylan Labs
  50. 8.9.1 Mylan Labs Company Information
  51. 8.9.2 Mylan Labs Business Overview
  52. 8.9.3 Mylan Labs Malaria Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mylan Labs Malaria Drugs Product Portfolio
  54. 8.9.5 Mylan Labs Recent Developments
  55. 8.10 Novartis
  56. 8.10.1 Novartis Company Information
  57. 8.10.2 Novartis Business Overview
  58. 8.10.3 Novartis Malaria Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novartis Malaria Drugs Product Portfolio
  60. 8.10.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Malaria Drugs Value Chain Analysis
  2. 9.1.1 Malaria Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Malaria Drugs Production Mode & Process
  6. 9.2 Malaria Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Malaria Drugs Distributors
  9. 9.2.3 Malaria Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst